Miz-hES10
MIZMe012-A
General
Cell Line |
|
| hPSCreg name | MIZMe012-A |
| Cite as: | MIZMe012-A (RRID:CVCL_9263) |
| Alternative name(s) |
Miz-hES10
|
| Cell line type | Human embryonic stem cell (hESC) |
| Similar lines | No similar lines found. |
| Last update | 31st August 2022 |
| User feedback | |
Provider |
|
| Generator |
MizMedi Hospital (MIZM)
Contact:
Medical Research Center |
| Derivation country | South Korea |
External Databases |
|
| Cellosaurus | CVCL_9263 |
| Wikidata | Q54905779 |
General Information |
|
| Publications | |
| * Is the cell line readily obtainable for third parties? |
No |
Donor Information
General Donor Information |
|
| Sex | male |
Phenotype and Disease related information (Donor) |
|
| Diseases | |
Ethics
| Alternatives to consent are available? | Yes |
| Alternatives to consent | |
| Alternative consent approval number | |
| How may genetic information associated with the cell line be accessed? |
hESC Derivation
| Embryo stage | Blastula with ICM and Trophoblast |
| Supernumerary embryos from IVF treatment? |
No
Other hESC source:
IVF
|
| ZP removal technique | Enzymatic |
| Cell isolation | Immunosurgery |
Culture Conditions
| Feeder cells |
mouse embryonic fibroblast cells Cellfinder Ont Id: EFO_0004040 |
|||||||||
| Passage method | Mechanically | |||||||||
| Medium |
Other medium:
Base medium: DMEM/F-12
Main protein source: Knock-out serum replacement Serum concentration: 20 % Supplements
|
Characterisation
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
| Alkaline Phosphatase |
Yes |
|
||||
| POU5F1 (OCT-4) |
Yes |
|
||||
| SSEA-1 |
No |
|
||||
| SSEA-3 |
Yes |
|
||||
| SSEA-4 |
Yes |
|
||||
| TRA 1-60 |
Yes |
|
||||
| TRA 1-81 |
Yes |
|
Differentiation Potency
Genotyping
Karyotyping (Cell Line) |
|
| Has the cell line karyotype been analysed? |
Yes
46XY
Passage number: 19
|
Other Genotyping (Cell Line) |
|
Login to share your feedback, experiences or results with the research community.